Quantum Biopharma Ltd. Files October 2025 6-K Report
Ticker: QNTM · Form: 6-K · Filed: Oct 1, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Oct 1, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, disclosure
TL;DR
Quantum Biopharma (fka FSD Pharma) filed its monthly 6-K report on Oct 1, 2025.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on October 1, 2025, for the month of October 2025. The company, incorporated in A6 and headquartered in Toronto, Ontario, is in the Pharmaceutical Preparations industry. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides routine disclosure for Quantum Biopharma Ltd. as a foreign private issuer, offering insights into its ongoing reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- October 2025 (date) — Reporting period
- October 1, 2025 (date) — Filing date
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of October 2025.
What is the former name of Quantum Biopharma Ltd.?
The former company name of Quantum Biopharma Ltd. was FSD Pharma Inc., with a date of name change on March 27, 2019.
Where is Quantum Biopharma Ltd. headquartered?
Quantum Biopharma Ltd.'s principal executive office is located at 1 Adelaide Street East, Suite 801, Toronto, Ontario M5C 2V9.
Does Quantum Biopharma Ltd. file an annual report under Form 20-F or Form 40-F?
Quantum Biopharma Ltd. indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, Pharmaceutical Preparations.
Filing Stats: 152 words · 1 min read · ~1 pages · Grade level 11.9 · Accepted 2025-10-01 07:50:06
Filing Documents
- f6k_093025.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 7KB
- 0001171843-25-006208.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: October 1, 2025 /s/ Donal Carroll Donal Carroll Chief Financial Officer EXHIBIT INDEX Exhibit Number Description 99.1 Press Release dated October 1, 2025